Global Search

Search articles, concepts, and chapters

J GlaucomaJanuary 20153 citations

Methyl-sulfonyl-methane (MSM)-induced acute angle closure.

Hwang Jeremy C, Khine Kay T, Lee Jennifer C, Boyer David S, Francis Brian A


AI Summary

MSM dietary supplement was linked to acute angle closure via ciliary body edema. This highlights MSM's potential to cause glaucoma, similar to other sulfa drugs, requiring consumer warnings.

Abstract

Purpose

To report the first case of presumed bilateral acute angle closure (AAC) secondary to ingestion of the dietary supplement, methyl-sulfonyl-methane (MSM).

Patient: A 35-year-old woman presented with bilateral AAC 1 week after starting multiple dietary supplements, one of which contained MSM. Ultrasound biomicroscopy demonstrated bilateral anterior rotation of the iris-lens diaphragm, ciliary body edema, and choroidal effusion. Four days after discontinuation of the supplements, her angle closure and uveal effusion resolved, and her best-corrected vision recovered to 20/20 bilaterally.

Discussion: Sulfa-based drugs have been reported to cause AAC, choroidal effusion, and ciliary body edema. In our patient, the coincidence of bilateral AAC with choroidal and ciliary body effusion that began 1 week after starting dietary supplements was suspicious for drug-induced AAC. The dietary supplement Basic Detox Nutrients contains MSM, the only constituent in the patient's medication list with a sulfonyl moiety. Given the similarities in chemical structure and clinical presentation, we postulate that MSM induces AAC in a manner similar to mechanisms previously described for other sulfa-based drugs.

Conclusions

As MSM continues to be used and studied for its anti-inflammatory and antioxidative properties, investigators and marketers will need to be cognizant of its potential to cause AAC and provide proper warning to consumers.


MeSH Terms

Acute DiseaseAdultAnterior Eye SegmentAnti-Inflammatory AgentsDietary SupplementsDimethyl SulfoxideFemaleGlaucoma, Angle-ClosureHumansIntraocular PressureMicroscopy, AcousticSulfonesVisual Acuity

Key Concepts4

Bilateral acute angle closure (AAC) was observed in a 35-year-old woman 1 week after starting multiple dietary supplements, one of which contained methyl-sulfonyl-methane (MSM).

DiagnosisCase seriesCase Reportn=1 patientCh13Ch19

Ultrasound biomicroscopy in a 35-year-old woman with presumed bilateral acute angle closure (AAC) secondary to methyl-sulfonyl-methane (MSM) demonstrated bilateral anterior rotation of the iris-lens diaphragm, ciliary body edema, and choroidal effusion.

DiagnosisCase seriesCase Reportn=1 patientCh4Ch13Ch19

Four days after discontinuation of dietary supplements containing methyl-sulfonyl-methane (MSM), a 35-year-old woman's acute angle closure and uveal effusion resolved, and her best-corrected vision recovered to 20/20 bilaterally.

TreatmentCase seriesCase Reportn=1 patientCh13Ch19

Methyl-sulfonyl-methane (MSM) is postulated to induce acute angle closure (AAC) in a manner similar to mechanisms previously described for other sulfa-based drugs, given the similarities in chemical structure and clinical presentation.

MechanismExpert OpinionCase Report Discussionn=1 patientCh13Ch19Ch29

Is this article assigned to the wrong chapter(s)? Let us know.